Chunlan Zhuang - Publications

Immunogenicity and Safety of Two-dose Schedules With Different Intervals of an ORF7-deficient Live Vaccine Candidate for Varicella: A Randomized, Double-blind, Controlled, Phase 2b Trial.

Journal: The Pediatric infectious disease journal

Published: February 18, 2026

Long-term protection from naturally acquired immunity against hepatitis E virus reinfection.

Journal: Nature communications

Published: July 29, 2025

Preliminary Cost-effectiveness and Cost-utility of Nasopharyngeal Carcinoma Screening with the Novel Biomarker Anti-BNLF2b Total Antibody.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: April 24, 2025

Hecolin vaccination strategies for hepatitis E outbreak control in resource-constrained settings.

Journal: The Lancet. Infectious diseases

Published: October 08, 2024

Effectiveness of a hepatitis E vaccine against medically-attended symptomatic infection in HBsAg-positive adults from a test-negative design study.

Journal: Nature communications

Published: September 01, 2024

Persistence of hepatitis E vaccine-induced antibody response across different dosage schedules and baseline serostatus.

Journal: NPJ vaccines

Published: August 21, 2024

The variations in the natural history of high-risk human papillomavirus infections in Chinese healthy women aged 27-45 years compared with 18-26 years: A prospective cohort study.

Journal: International journal of cancer

Published: August 14, 2024

A randomized phase I trial of intranasal SARS-CoV-2 vaccine dNS1-RBD in children aged 3-17 years.

Journal: NPJ vaccines

Published: July 09, 2024

Active surveillance of hepatitis E: a 10-year epidemiological analysis in a city in eastern China.

Journal: Emerging microbes & infections

Published: June 26, 2024

Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial.

Journal: Lancet (London, England)

Published: July 21, 2023

Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Journal: The Lancet. Respiratory medicine

Published: May 31, 2023

Safety of hepatitis E vaccination for pregnancy: a post-hoc analysis of a randomized, double-blind, controlled phase 3 clinical trial.

Journal: Emerging microbes & infections

Published: March 06, 2023